Key facts
- It has raised $150K; the latest was Seed Round ($150K) in Dec 2025.
- Notable investors include Right Side Capital Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Circadify
- ·The full record, as it builds
Funding rounds
No funding rounds for Circadify are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Circadify
Developer of an AI-powered, contactless vital sign monitoring mobile application designed for health platforms, insurers, and telemedicine providers. The company offers camera-based physiological sensing using rPPG, real-time heart rate and HRV detection, respiratory rate monitoring, blood pressure proxies, stress and recovery indices, enabling blood pressure patients to monitor without requiring wearables or external hardware.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Website
- circadify.com/
- Ownership
- Privately Held (backing)
Circadify doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Circadify shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Circadify in its N-PORT filings yet. We sweep new filings monthly.